Elevated plasma levels of GPNMB in PD patients are linked to its interaction with α-synuclein, which exacerbates PD pathogenesis by promoting the uptake of pathological α-synuclein aggregates [19]. The gene discussed is GPNMB; the disease is Parkinson disease.